Biolidics launches IPO to raise S$6.1m
Add BT as a preferred source
Singapore
MEDICAL technology company Biolidics on Tuesday launched an initial public offering (IPO) of 27.5 million new shares at S$0.28 each. The placement is in conjunction with its proposed listing on the Catalist board on Dec 19.
The shares will be placed out to retail and institutional investors in Singapore, and represent 11.34 per cent of the company's enlarged share capital. Upon completion of the IPO, Biolidics' market capitalisation is expected to be S$67.9 million.
TRENDING NOW
Dim sum chain Tim Ho Wan to close first Singapore outlet as part of Plaza Singapura’s redevelopment
What’s wrong with Orchard Road? Experts weigh in on the street’s cachet and its future
Sunway MCL, CSC make bold bet on River Valley site with S$1,730 psf ppr bid at S$750.6 million
DBS sees 46% upside for Jardine Matheson; analysts expect it to surpass ‘conservative’ targets
